Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This randomized clinical trial assesses the efficacy of ivermectin treatment in preventing progression to severe disease among high-risk patients with COVID-19 in Malaysia.
國內專家認為抗寄生蟲老藥「伊維菌素」對治療COVID-19療效佳。指揮中心今天說,所有證據不支持伊維菌素可用於預防或治療COVID-19,目前此藥為專案進口,未納入指引。
網傳「服用伊維菌素後,巴西、秘魯、印度疫情大幅下降」的訊息。專家指出,過去有部分文章指稱伊維菌素好像對控制新冠肺炎有幫助,但從比較嚴謹的醫學角度、實證醫學看來,目前沒有足夠證據認為伊維菌素有幫助,所以未被納入正式的治療指引。專家表示,即使是在真實世界進行的試驗,仍要看該研究做得夠不夠嚴謹,需考量很多
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.